Lifeward Ltd. (LFWD)

ReWalk Robotics Ltd. (NASDAQ:LFWD) to Post Q2 2024 Earnings of ($0.53) Per Share, HC Wainwright Forecasts

ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) – Analysts at HC Wainwright lifted their Q2 2024 earnings per share (EPS) estimates for ReWalk Robotics in a research report issued on Thursday, May 16th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings of ($0.53) per share for the quarter, up from their previous estimate of ($0.56). HC Wainwright currently has a “Buy” rating and a $13.00 target price on the stock. The consensus estimate for ReWalk Robotics’ current full-year earnings is ($1.94) per share. HC Wainwright also issued estimates for ReWalk Robotics’ Q3 2024 earnings at ($0.41) EPS, Q4 2024 earnings at ($0.26) EPS, FY2024 earnings at ($1.94) EPS, Q1 2025 earnings at ($0.15) EPS, Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.05) EPS, Q4 2025 earnings at $0.00 EPS, FY2025 earnings at ($0.30) EPS, FY2027 earnings at $0.98 EPS and FY2028 earnings at $1.43 EPS. ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last announced its quarterly earnings results on Tuesday, February 27th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.91) by $0.56. ReWalk Robotics had a negative return on equity of 33.41% and a negative net margin of 134.52%. The company had revenue of $6.88 million for the quarter, compared to the consensus estimate of $7.20 million. ReWalk Robotics Stock Performance Shares of NASDAQ:LFWD opened at $5.06 on Monday. ReWalk Robotics has a 1 year low of $3.90 and a 1 year high of $9.10. The stock has a market cap of $43.52 million, a P/E ratio of -1.63 and a beta of 2.06. The firm’s 50-day simple moving average is $5.00. Institutional Trading of ReWalk Robotics An institutional investor recently bought a new position in ReWalk Robotics stock. Kent Lake Capital LLC acquired a new stake in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 157,361 shares of the company’s stock, valued at approximately $823,000. Kent Lake Capital LLC owned approximately 1.85% of ReWalk Robotics as of its most recent filing with the SEC. Hedge funds and other institutional investors own 26.76% of the company’s stock. ReWalk Robotics Company Profile (Get Free Report) ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.